Effects of glucagon-like peptide-1 receptor agonists on renal function
Open Access
- 1 January 2013
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 4 (5) , 190-201
Abstract
Effects of glucagon-like peptide-1 receptor agonists on renal functionKeywords
This publication has 86 references indexed in Scilit:
- GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressureNature Medicine, 2013
- Medical Management and Strategies to Prevent Coronary Artery Disease in Patients with Type 2 Diabetes MellitusPostgraduate Medicine, 2013
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- The Impact of Current and Novel anti-diabetic Therapies On Cardiovascular RiskFuture Cardiology, 2012
- Choosing between GLP-1 Receptor Agonists and DPP-4 Inhibitors: A Pharmacological PerspectiveJournal of Nutrition and Metabolism, 2012
- Regulation of Na+/H+exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2009
- Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cellsRegulatory Peptides, 2007
- CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKCKidney International, 2002
- Transforming Growth Factor β in Diabetic NephropathyDiabetes/Metabolism Research and Reviews, 1996
- Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.Endocrinology, 1993